To address this question, the RCC cell line 786-O, a standard model for VHL−/−, was used to assess HIF-2α distribution in the cellular compartments (nucleus vs. cytoplasm), before and after the treatment with β-blockers, by an immunofluorescence confocal microscopy assay. Here, EPAS1 is linked to renal cell carcinoma.